Core-008
核心008
基本信息
- 批准号:10414775
- 负责人:
- 金额:$ 33.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-01 至 2023-11-15
- 项目状态:已结题
- 来源:
- 关键词:AwardCapital FinancingClinicalClinical SciencesCollaborationsColoradoCourse ContentDevelopmentEconomic DevelopmentEcosystemEducationEntrepreneurshipFacultyFosteringFundingGoalsHealthInfrastructureInnovation CorpsInstitutesInternationalInvestmentsLeadMentorshipNational Center for Advancing Translational SciencesProcessResourcesRewardsScienceServicesTrainers TrainingTrainingTraining ProgramsTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiescareercommercializationexperiencegraduate studentinnovationproduct developmentprogramstraining opportunity
项目摘要
The Innovation Ecosystem (Partnering for Innovation Value Optimization and Accelerated Translation
[PIVOT]) program will embrace innovation and commercial translation to advance biomedical discoveries into
the marketplace. Through this Optional Function of the CCTSI, we will develop and sustain an innovation
program to educate, train and develop our workforce in commercial value translation; to support the technical
development of commercializable innovation; and to demonstrate value and health impact of clinical and
translational science innovation by providing access to accelerator venture capital funding, domain expertise,
and commercialization mentorship. The overall goal of PIVOT is to provide a seamless, multi-level investigatorfacing
infrastructure supporting the commercialization and product development of innovative ideas and, in the
process, support and academically reward entrepreneurship. We will achieve these goals through the following
specific aims: Aim 1: Workforce. Catalyze an academic entrepreneur culture and workforce by (a) disseminating
and expanding the reach of bio-entrepreneurship training opportunities, (b) fostering entrepreneurial networking,
and (c) demonstrating career trajectories for faculty and graduate students who are clinical and translational
science innovators. Aim 2: Development. Accelerate the development of commercializable innovation through
customer discovery by Innovation-Corps (I-Corps™) teams and promote combined usage of I-Corps and Team
Science training for innovation teams receiving CCTSI pilot awards. Aim 3: Demonstrate impact. Accelerate
health impact demonstration through active navigation to resources within the CCTSI ecosystem which provide
commercialization mentorship, domain expertise, and accelerator funding. The CCTSI PIVOT program will serve
as an integrator-navigator and resource multiplier to expand and extend the reach of entrepreneurial investment
and infrastructure support provided by University of Colorado and Colorado State University and the Colorado
Office of Economic Development and International Trade. PIVOT will also capitalize on two unique NIH workforce
training programs in Colorado: the Broadening Experiences in Scientific Training (BEST) award for graduate
trainees in clinical and translational sciences; and the I-Corps™ Train-the-Trainer program at NCATS to develop
a scalable short-course curriculum and common metrics adapted to the needs of clinical and translational
science programs that will be disseminated across the CTSA consortium. In collaboration with an extensive
network of state-wide, national and institutional innovation and entrepreneurship partnerships, PIVOT will lead a
major academic shift within the CCTSI ecosystem by embracing innovation and commercial translation to
advance biomedical discoveries into the marketplace. We will foster a culture that supports startup incubation
and provides education and practical training to help academic ventures develop commercially-viable products
and services.
创新生态系统(合作创新价值优化和加速转化)
[PIVOT])计划将拥抱创新和商业转化,将生物医学发现推进到
通过 CCTSI 的这一可选功能,我们将开发并维持创新。
教育、培训和发展我们的商业价值转化员工队伍的计划;
开发可商业化的创新;并展示临床和健康的价值和影响
通过提供加速器风险投资资金、领域专业知识、
PIVOT 的总体目标是提供无缝、多层次的研究人员指导。
支持创新理念商业化和产品开发的基础设施,
我们将通过以下方式实现这些目标。
具体目标: 目标 1:通过 (a) 传播学术企业家文化和劳动力。
以及生物创业的影响力扩大培训机会,(b) 促进创业网络,
(c) 展示临床和转化教师和研究生的职业轨迹
目标 2:通过加速商业化创新的发展。
Innovation-Corps (I-Corps™) 团队发现客户并促进 I-Corps 和 Team 的结合使用
为获得 CCTSI 试点奖项的创新团队提供科学培训,目标 3:加速发挥影响力。
通过主动导航 CCTSI 生态系统内的资源来展示健康影响,这些资源提供
CCTSI PIVOT 计划将提供商业化指导、领域专业知识和加速器资金。
作为整合者、领航者和资源倍增器,扩大和延伸创业投资的范围
科罗拉多大学、科罗拉多州立大学和科罗拉多大学提供的基础设施支持
经济发展和国际贸易办公室还将利用 NIH 的两名独特劳动力。
科罗拉多州的培训计划:毕业生科学培训拓宽经验 (BEST) 奖
临床和转化科学领域的学员;以及 NCATS 的 I-Corps™ 培训师计划,以开发
适应临床和转化需求的可扩展的短期课程和通用指标
将与广泛的 CTSA 联盟合作传播的科学计划。
PIVOT 将在全州、国家和机构的创新和创业伙伴关系网络中引领
通过拥抱创新和商业翻译,CCTSI 生态系统内发生了重大学术转变
我们将培育一种支持初创企业孵化的文化。
并提供教育和实践培训,帮助学术企业开发商业上可行的产品
和服务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD J. SOKOL其他文献
RONALD J. SOKOL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD J. SOKOL', 18)}}的其他基金
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926512 - 财政年份:2019
- 资助金额:
$ 33.52万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
9926131 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
CCTSI Participation in the National COVID Cohort Collaborative (N3C)
CCTSI 参与国家新冠肺炎队列协作 (N3C)
- 批准号:
10164981 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
10414766 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
Colorado Clinical and Transational Sciences Institute
科罗拉多临床和转化科学研究所
- 批准号:
10402976 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
相似国自然基金
不完美资本市场下供应链的绿色信贷融资决策及补贴机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
国家资本结构与企业债务融资:机制分析与政策设计
- 批准号:
- 批准年份:2022
- 资助金额:45 万元
- 项目类别:面上项目
对外融资结构与宏观审慎性的资本管制政策:基于国家治理水平的视角
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
数据资本、混合控制与企业投融资决策
- 批准号:72002006
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
基于不完全信息的或有资本设计及其投融资分析
- 批准号:71801185
- 批准年份:2018
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma
GPER 激动剂作为皮肤和葡萄膜黑色素瘤治疗药物的开发
- 批准号:
10602468 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
Development of GPER Agonists as Therapeuticsfor Cutaneous and Uveal Melanoma
GPER 激动剂作为皮肤和葡萄膜黑色素瘤治疗药物的开发
- 批准号:
10461469 - 财政年份:2018
- 资助金额:
$ 33.52万 - 项目类别:
Development of Poloxamer-188 for the Treatment of Muscular Dystrophy Associated H
开发用于治疗 H 相关性肌营养不良症的 Poloxamer-188
- 批准号:
7608997 - 财政年份:2009
- 资助金额:
$ 33.52万 - 项目类别: